A randomized, controlled trial of prulifloxacin as conversion therapy after intravenous carbapenem in the treatment of acute pyelonephritis caused by third generation cephalosporin resistant pathogens: A pilot study (2023)

Title           :  A randomized, controlled trial of prulifloxacin as conversion therapy after intravenous carbapenem in the treatment of acute pyelonephritis caused by third generation cephalosporin resistant pathogens: A pilot study

Researcher       : Apichot So-Ngern,Supunnee Jirajariyavej, Huttaya Thuncharoon, Nuttha Khunthupat, Teerachai Chantarojanasiri and Preecha Montakantikul

Link to article:  Clinical and Translational Science, Volume 16,  Issue 12, December 2023, Pages 2709-2718. https://doi.org/10.1111/cts.13665

Journal : Clinical and Translational Science / in Scopus

Citation : So-Ngern A, Jirajariyavej S, Thuncharoon H, Khunthupat N, Chantarojanasiri T and Montakantikul P. (2023). A randomized, controlled trial of prulifloxacin as conversion therapy after intravenous carbapenem in the treatment of acute pyelonephritis caused by third generation cephalosporin resistant pathogens: A pilot study. Clinical and Translational Science, 16(12), 2709-2718. https://doi.org/10.1111/cts.13665

ฐานข้อมูลงานวิจัย มหาวิทยาลัยสยาม  :  https://e-research.siam.edu/kb/a-randomized-controlled-trial-of-prulifloxacin/